You can buy or sell OpGen and other stocks, options, ETFs, and crypto commission-free!
OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It helps to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). Read More The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
52 Week High
52 Week Low
-$0.17 per share
-$0.15 per share